Page last updated: 2024-11-06

floxuridine and Carcinoma, Bronchial

floxuridine has been researched along with Carcinoma, Bronchial in 2 studies

Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tagett, JP1
Vaitkevicius, VK1
Walt, AJ1
Selawry, OS1

Reviews

1 review available for floxuridine and Carcinoma, Bronchial

ArticleYear
Monochemotherapy of bronchogenic carcinoma withs special reference to cell type.
    Cancer chemotherapy reports. Part 3, 1973, Volume: 4, Issue:2

    Topics: Adenocarcinoma; Alkylating Agents; Antineoplastic Agents; Carcinoma, Bronchogenic; Cytarabine; Dacti

1973

Other Studies

1 other study available for floxuridine and Carcinoma, Bronchial

ArticleYear
Bronchial artery cannulation at thoracotomy for continous chemotherapy perfusion in dogs.
    Oncology, 1968, Volume: 22, Issue:2

    Topics: Animals; Bronchial Arteries; Carcinoma, Bronchogenic; Catheterization; Chemotherapy, Cancer, Regiona

1968